A review describes possible protective effects of ginseng compounds in ALS models
Original source
The role of Panax ginseng in neurodegenerative disorders: mechanisms, benefits, and future directions. (opens in a new tab)Compass summarised this from the study's abstract.
Study details
- Study type
- Review
- Studied in
- Human, Animal
A 2025 review examined ginseng and its active compounds, called ginsenosides, in neurodegenerative diseases including amyotrophic lateral sclerosis (ALS). It reports that studies in ALS models found improvements in motor function, longer neuronal survival and reduced cellular toxicity.
Why this matters
These findings may help guide research into how ginseng compounds affect disease-related processes. They do not show that ginseng treats ALS in people or change current treatment, because the evidence described is from models rather than clinical studies.
Limitations and context
This is a review, not a new clinical trial. The source does not provide the number, design or detailed results of the ALS studies it discusses, and it does not establish safety or effectiveness in people with ALS. Clinical research would be needed to determine whether these findings apply to patients.